Copy
View this email in your browser

EUCAN Newsletter #1

September 23, 2020

EUCAN Dissemination and Communication Group Newsletter

Welcome to the first edition of the EUCAN Dissemination and Communication Group's newsletter. The group consists of representants from the six projects (CINECA, EUCANCan, EUCAN-Connect, euCanSHare, iReceptor Plus, ReCoDID) that were funded under the Horizon 2020 call SC1-BHC-05-2018

In this pilot newsletter, we have gathered a series of interviews with the EUCAN projects’ respective coordinators, listed recent publications by the consortia, and collected information on relevant upcoming events. We hope you enjoy the read. 

Best wishes,
The EUCAN Dissemination and Communication Group

PS. Please share this newsletter with your colleagues and network.

Interviews with key EUCAN consortia members 

Highlighted articles 

After Schrems II: EUCANCan colleagues discuss the ramifications in GA4GH's Sept GDPR Brief

GA4GH’s latest GDPR Brief, co-written by the EUCANCan colleagues Fruzsina Molnár-Gábor and Michael Beauvais, examines the ramifications of the European Court of Justice’s Schrems II judgment on 16 July. Read more »
 

iReceptor Plus: Immune Sequences

iReceptor Plus Offers Access to 200 Million Immune Sequences from COVID-19 Patients. The consortium has established a large-scale database of sequencing data of T and B cell receptors designed to facilitate diagnostic, therapeutic and vaccine research for COVID-19. Read more » 
 

CINECA: Sustainability and Small and Medium-sized Enterprises (SMEs)

Many of CINECA’s objectives have direct relevance to research topics ranging from computer science through to genomics. As such there will be classical outputs from the project through papers, publishing etc. after the project has finished. Read more »

ReCoDID: Creation of a new WP on global response to COVID-19

The new ReCoDID WP will help maximize the utility of the recently launched EMBL-EBI COVID-19 data portal by enabling the sharing and analysis of linked, participant-level clinical-epidemiological and OMICs data related to the novel coronavirus, SARS-CoV-2. Read more »

Recent scientific publications 

  • Campbell et al.  Bayesian adjustment for preferential testing in estimating the COVID-19 infection fatality rate: Theory and methods. July 2020. Pre-Print.
  • Campbell, P.J., Getz, G., Korbel, J.O. et al. Pan-cancer analysis of whole genomes. Nature 57882–93 (2020). DOI: 10.1038/s41586-020-1969-6 
  • De Jong et al. Individual participant data meta‐analysis of intervention studies with time‐to‐event outcomes: A review of the methodology and an applied example. Wiley Research Synthesis Method, November 2019. DOI: 10.1002/jrsm.1384
  • Devriendt et al. Data sharing platforms and the academic evaluation system. July 2020. Pre-Print.
  • Ostmeyer et al. Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue. Cancer Research. April 2019. DOI: 10.1158/0008-5472.CAN-18-2292
  • Phillips et al. Genomics: Data sharing needs an international code of conduct: Efforts to protect people’s privacy in a massive international cancer project offer lessons for data sharing. Nature 578, 31-33, February 2020. DOI : 10.1038/d41586-020-00082-9
  • Martin-Isla et al. Image-Based Cardiac Diagnosis With Machine Learning: A Review. Front. Cardiovasc. Med., January 2020. DOI: doi.org/10.3389/fcvm.2020.00001

Upcoming events

Funding acknowledgement CINECA

 
CINECA has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825775.
 
CINECA has received funding from the Canadian Institute of Health Research under CIHR grant number #404896
 

Funding acknowledgement EUCAN Connect

 
EUCAN Connect has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 824989. 
 

Funding acknowledgement EUCANCan

 
EUCANCan has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825835. EUCANCan also gratefully acknowledges funding from the Canadian Institute of Health Research (CIHR) under grant number CDF-160202

Funding acknowledgement euCanSHare

 
euCanSHare has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825903
  
All Canadian project partners in the euCanShare consortium have been funded by the Canadian Institutes of Health Research and the Fonds de recherche du Québec – Santé
 

Funding acknowledgement iReceptor plus 

 
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825821 and the Canadian Institutes of Health Research (CIHR). 
 

Funding acknowledgement ReCoDID

  
The ReCoDID project has received funding from European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No.825746and is supported by the Canadian Institutes of Health Research, Institute of Genetics (CIHR-IG) under Grant Agreement N° 01886-000.



If you do not wish to receive future updates from the EUCAN Dissemination & Communication Group, please send an email to a.guske@linq-management.com